Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample
May 6, 2020
Presenters:
Casey Lester, MD
Carl Feinstein, MD
Target Audience
This activity was developed for physicians along with nurses and ancillary staff.
Learning Objectives
At the end of this presentation, participants should be better able to:
- Discuss the latest evidence of the role of genetic predisposition to psychoses in the development of substance-induced psychotic disorder (SIPD)
- Summarize the latest evidence regarding the roles of drug use and genetic predisposition in the progression from SIPD to schizophrenia
- Identify known factors that signify higher risk of progression from SIPD to schizophrenia
University of California School of Medicine at Riverside
Riverside, CA
92521
United States
Available Credit
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance